NCT02316236

Dexmedetomidine to Improve Outcomes During Emergence From Retroperitoneal Laparoscopic Surgery

Effect of Dexmedetomidine on Outcomes During Emergence From Retroperitoneal Laparoscopic Surgery

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 66 (actual)
• Sponsor: Air Force Military Medical University, China · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The study is to observe whether dexmedetomidine could reduce agitation during emergence from general anesthesia in patients undergoing retroperitoneal laparoscopic surgery.

Detailed description

Agitation during emergence is frequent after retroperitoneal urologic surgery. Dexmedetomidine is alpha-2 receptor agonist which shows sedative and algesic effect. In this study we will compare the effect of dexmedetomidine given by different protocols on emergence agitation.

Conditions

• Anesthesia

Interventions

Type	Name	Description
DRUG	dexmedetomidine	an alpha-2 receptor agonist
OTHER	loading dose	0.8ug/kg of dexmedetomidine is given in 10 minutes
OTHER	sustaining dose	0.4ug/kg/min of dexmedetomidine is given

Timeline

• Start date: 2014-12-10
• Primary completion: 2015-08-12
• Completion: 2015-08-13
• First posted: 2014-12-12
• Last updated: 2022-05-26

Locations

1 site across 1 country: China